adMare BioInnovations
Matthew Carlyle, CFA, ICD.D has extensive experience in the finance sector, with a focus on the biotechnology and pharmaceutical industries. Matthew is currently the Chief Operating Officer and CFO at adMare BioInnovations, where they have been since 2019. Prior to this, Matthew held the position of Executive Vice-President and CFO at adMare BioInnovations. In 2019, they also served as the Chief Financial Officer at NEOMED Innovation Centre. Matthew's previous experience includes roles as the Chief Financial Officer at The Centre for Drug Research & Development (CDRD) and Chief Financial Officer at Allon Therapeutics Inc. Matthew also served as Partner at NDI Capital Inc. and held executive positions at Viable Healthworks Corp., Neuro Discovery, and ThoughtShare Communications Inc. Matthew's career spans over two decades, showcasing their expertise in financial management and strategic development.
Matthew Carlyle, CFA, ICD.D attended Queen's University. Matthew holds a Chartered Financial Analyst (CFA) certification from the CFA Institute and an Institute of Corporate Directors (ICD.D) certification obtained in 2019.
adMare BioInnovations
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability. www.admarebio.com Avec des bureaux situés à Montréal, Vancouver et Toronto, adMare développe le secteur canadien des sciences de la vie d’un océan à l’autre. Grâce à sa riche expérience en matière de découvertes scientifiques concurrentielles à l’échelle internationale, le Canada est prêt à devenir un chef de file mondial dans le domaine des sciences de la vie. C’est pour concrétiser cet objectif qu’adMare BioInnovations tire parti de son expertise technique et commerciale, de son infrastructure de recherche et développement spécialisée et de son capital d’investissement pour développer de solides entreprises des sciences de la vie, des écosystèmes robustes et les talents prêts à travailler dans l’industrie. Nous réinvestissons nos bénéfices dans l’industrie canadienne pour assurer son maintien à long terme. www.admarebio.com/fr